These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33054832)

  • 1. French People's positions on supervised injection facilities for drug users.
    Munoz Sastre MT; Kpanake L; Mullet E
    Subst Abuse Treat Prev Policy; 2020 Oct; 15(1):79. PubMed ID: 33054832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping and comparing French people's positions regarding restrictive control policies: a pilot study.
    Castanié S; Munoz Sastre MT; Kpanake L; Mullet E
    Subst Abuse Treat Prev Policy; 2020 Mar; 15(1):25. PubMed ID: 32192501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia.
    Harris RE; Richardson J; Frasso R; Anderson ED
    Int J Drug Policy; 2018 Feb; 52():56-61. PubMed ID: 29241143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
    Davidson PJ; Lopez AM; Kral AH
    Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a medically supervised injection facility among street youth.
    Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
    J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City.
    Mitra S; Rachlis B; Scheim A; Bardwell G; Rourke SB; Kerr T
    Harm Reduct J; 2017 Jul; 14(1):46. PubMed ID: 28709471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in public order after the opening of an overdose monitoring facility for people who inject drugs.
    León C; Cardoso LJP; Johnston S; Mackin S; Bock B; Gaeta JM
    Int J Drug Policy; 2018 Mar; 53():90-95. PubMed ID: 29294417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
    Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
    PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of supervised injection facilities and injection risk behaviours among young drug injectors.
    Bravo MJ; Royuela L; De la Fuente L; Brugal MT; Barrio G; Domingo-Salvany A;
    Addiction; 2009 Apr; 104(4):614-9. PubMed ID: 19215603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility.
    Kerr T; Tyndall MW; Zhang R; Lai C; Montaner JS; Wood E
    Am J Public Health; 2007 Jul; 97(7):1228-30. PubMed ID: 17538061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada.
    Cruz MF; Patra J; Fischer B; Rehm J; Kalousek K
    Int J Drug Policy; 2007 Jan; 18(1):54-61. PubMed ID: 17689344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
    Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD
    Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol.
    Auriacombe M; Roux P; Briand Madrid L; Kirchherr S; Kervran C; Chauvin C; Gutowski M; Denis C; Carrieri MP; Lalanne L; Jauffret-Roustide M;
    BMJ Open; 2019 Feb; 9(2):e023683. PubMed ID: 30796121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.
    Hyshka E; Bubela T; Wild TC
    Addiction; 2013 Mar; 108(3):468-76. PubMed ID: 23286831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of public support toward federal funding for harm reduction strategies.
    Kulesza M; Teachman BA; Werntz AJ; Gasser ML; Lindgren KP
    Subst Abuse Treat Prev Policy; 2015 Jun; 10():25. PubMed ID: 26122408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Between Emergency Department Visits: The Role of Harm Reduction Programs in Mitigating the Harms Associated With Injection Drug Use.
    Macias-Konstantopoulos W; Heins A; Sachs CJ; Whiteman PJ; Wingkun NG; Riviello RJ
    Ann Emerg Med; 2021 May; 77(5):479-492. PubMed ID: 33579588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation.
    Krüsi A; Small W; Wood E; Kerr T
    AIDS Care; 2009 May; 21(5):638-44. PubMed ID: 19444673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of Vancouver's supervised injection facility.
    Bayoumi AM; Zaric GS
    CMAJ; 2008 Nov; 179(11):1143-51. PubMed ID: 19015565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of on-site detoxification services co-located with a supervised injection facility.
    Gaddis A; Kennedy MC; Nosova E; Milloy MJ; Hayashi K; Wood E; Kerr T
    J Subst Abuse Treat; 2017 Nov; 82():1-6. PubMed ID: 29021106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.